A couple of Big Pharma articles.
Canadian pharmacies face drug shortages
ST. PAUL, Minn., April 13 (UPI) -- Canadian pharmacists report serious drug shortages because pharmaceutical companies have cut off supplies to pharmacies that sell to U.S. seniors.
"Our pharmacies are under incredible pressure right now. The supply issue is drastic," Dave Mackey, president of the Canadian International Pharmacist Association, told reporters.
In January, Pfizer cut off shipments of its drugs to more than 70 Canadian pharmacies that sell to U.S. customers. Many U.S. seniors find they can purchase their medications in Canada far cheaper than at U.S. pharmacies.
Pfizer officials, who did not return phone calls to United Press International for comment, have said they are concerned about their Canadian pipeline and allowing drug reimportation could lead to counterfeiting and result in a safety issue.
Mackey said other pharmaceutical companies are joining Pfizer in what he called "blacklisting" the Canadian pharmacies.
He made his comments during a news conference announcing the Minnesota Senior Federation's "Pfix Pfizer" campaign -- a multi-state protest of Pfizer's actions.
washingtontimes.com
Canadian Internet Pharmacies Seek Supplies
THERESA AGOVINO
NEW YORK - Canadian Internet pharmacies are turning to Europe for supplies, as pharmaceutical companies are choking off prescription drugs sent north of the border to stop the flow of cheap medicines back to the United States.
In the last six weeks, several drug makers have increasingly cut supplies to Canada, creating drug shortages for Internet pharmacies. Pfizer Inc., for example, cut off two Canadian wholesalers in February for supplying drugs to companies that were exporting them. Pfizer later resumed shipments to both companies after they agreed to stop doing so.
Canadameds.com will start selling drugs from England on its Web site within the next week, and Universaldrugstore.com plans to start selling medicines from Ireland within the next month. Universaldrugstore.com has also found another possible supplier in New Zealand and plans to check its safety standards before offering its medicines to clients.
Crossborderpharmacy.com is negotiating with several pharmacies in England and hopes to announce an agreement in three weeks.
Europe, like Canada, has government price controls that keep prescription drug prices well below those in America. Drugs in Canada are up to 50 percent cheaper than they are in the United States.
"We have to stay a step ahead of the drug companies," said Jeff Yhl, president of universaldrugstore.com. "We have to scour the world for safe supply for our customers."
Canadian Internet pharmacies' moves to expand their supplier base comes at a time when many cities, states and members of Congress are looking to importation as a way to curb spiraling drug costs.
Earlier this month, New Hampshire became the third state to offer residents a link to a Canadian pharmacy on its official Web site. Meanwhile Sen. Charles Grassley, R-Iowa, introduced legislation that would allow drugs to be imported from Canada initially and then other countries. The bill would punish companies that limit drug sales to Canada.
AARP, the lobbying group for older Americans, recently ran a television campaign that urged Congress to find ways to lower drug costs and noted importation was an option.
The pharmaceutical industry vehemently opposes importation. It is technically illegal for Americans to import drugs but regulators have turned a blind eye to individuals who do so, and have warned them about the potential dangers of buying medicines abroad.
Jeff Trewhitt, spokesman for the Pharmaceutical Research and Manufacturers of America, said importing drugs from Europe poses the same risks as buying them from Canada: They may be counterfeit or unsafe because of improper storage or labeling. Importing price controls means less money for research and development, he said.
Patients having difficulty paying for drugs should shop around or explore drug companies' patient assistance programs, Trewhitt said.
Pfizer, Eli Lilly and Co. and AstraZeneca PLC have taken additional steps toward limiting supply to Canada recently. Lilly spokesman Ed Sagebiel wouldn't comment on Canadian pharmacies adding to their suppliers but said his company cut supply to avoid aiding an illegal practice.
Drug company actions have taken a toll.
Yhl said it takes a week to get Pfizer's pain reliever Celebrex and has suggested to patients they might want to ask their doctors about Vioxx, a rival drug made by Merck & Co. Pfizer drug Arthrotec also takes a week to secure, Yhl said. Canadameds.com said it takes three to five days to get many Pfizer drugs.
"Supply is really getting tight all around. There is only so much product to go around," said Dave Schioler, vice president of operations and administration at Canadameds.com.
Schioler said countries within the European Union represent an excellent source for expanding supply because it would be much harder for drug companies to limit supply to all of them. He said that if drug companies curb sales to England, for example, pharmacies there could buy the drugs from another EU member.
All three Web sites said they have investigated the European pharmacies they will work with to ensure high safety and regulatory standards. Patients will be given the option of purchasing the European drugs and the medicines would be shipped directly from Europe to U.S. consumers. Prices would still be less expensive than the United States, but some medicines would be more expensive than their Canadian counterparts, others less.
Yhl didn't believe patients would be overly concerned about buying drugs from Ireland as long as they save money because it is an English-speaking, developed country with high safety standards.
"I think our patients trust us," Yhl said.
mercurynews.com
lurqer |
